(Q3)Jan 31, 2024 | (Q2)Oct 31, 2023 | (Q1)Jul 31, 2023 | (FY)Apr 30, 2023 | (Q4)Apr 30, 2023 | (Q3)Jan 31, 2023 | (Q2)Oct 31, 2022 | (Q1)Jul 31, 2022 | (FY)Apr 30, 2022 | (Q4)Apr 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 5.85%-196.98K | -2,338.82%-1.6M | -13,667.82%-1.16M | -7,796.87%-2.12M | -11,559.73%-1.84M | -935.38%-209.23K | -65.74K | -8.42K | -26.91K | 16.07K |
Net income from continuing operations | 92.86%-227.03K | -453.43%-536.02K | -5,493.35%-1.31M | -21,255.27%-5.52M | -14,508.16%-2.43M | -36,051.44%-3.18M | ---96.86K | ---23.49K | ---25.83K | --16.88K |
Depreciation and amortization | --6.51K | --6.51K | --3.17K | --6.51K | --6.51K | ---- | --0 | --0 | --0 | ---- |
Asset impairment expenditure | ---- | ---- | ---- | ---- | ---- | --218.27K | ---- | ---- | ---- | ---- |
Remuneration paid in stock | ---- | ---- | ---- | --983.5K | ---- | ---- | ---- | ---- | --0 | ---- |
Other non cashItems | -101.52%-38.62K | ---359.83K | ---452.63K | --2.39M | ---153.82K | --2.55M | ---- | ---- | ---- | ---- |
Change In working capital | -69.97%62.15K | -2,394.36%-713.91K | 3,905.64%603.37K | 830.38%7.91K | -30,065.07%-245.24K | 1,913.96%206.97K | --31.12K | --15.06K | ---1.08K | ---813 |
-Change in receivables | 183.95%63.49K | 4,297.39%67.49K | -4,740.46%-48.21K | -11,901.39%-155.42K | -13,489.26%-77.19K | -34,166.22%-75.63K | ---1.61K | ---996 | ---1.3K | ---568 |
-Change in payables and accrued expense | -100.47%-1.34K | -2,487.87%-781.41K | 3,957.41%651.58K | 76,941.51%163.33K | -68,493.88%-168.06K | 2,529.50%282.6K | --32.72K | --16.06K | --212 | ---245 |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 5.85%-196.98K | -2,338.82%-1.6M | -13,667.82%-1.16M | -7,796.87%-2.12M | -11,559.73%-1.84M | -935.38%-209.23K | ---65.74K | ---8.42K | ---26.91K | --16.07K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -78.13K | -102.70%-56.52K | -21.61K | 0 | -27.88K | |||||
Net PPE purchase and sale | ---- | ---- | ---- | ---78.13K | ---56.52K | ---21.61K | ---- | ---- | --0 | --0 |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | ---- | ---- | ---- | ---78.13K | -102.70%-56.52K | ---21.61K | ---- | ---- | --0 | ---27.88K |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 0 | 0 | 2.22M | 11,265.60%3.63M | 0 | 11,265.60%3.63M | 0 | 0 | 31.96K | 0 |
Net common stock issuance | --0 | --0 | --2.22M | 11,265.60%3.63M | --0 | 11,265.60%3.63M | --0 | --0 | --31.96K | --0 |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | --0 | --0 | --2.22M | 11,265.60%3.63M | --0 | 11,265.60%3.63M | --0 | --0 | --31.96K | --0 |
Net cash flow | ||||||||||
Beginning cash position | 3,641.22%991.13K | 2,712.91%2.59M | 1,420.50%1.53M | 5.29%100.66K | 2,948.47%3.43M | -73.70%26.49K | --92.23K | --100.66K | --95.6K | --112.47K |
Current changes in cash | -105.79%-196.98K | -2,338.82%-1.6M | 12,729.61%1.06M | 28,184.97%1.43M | -15,967.86%-1.9M | 28,838.96%3.4M | ---65.74K | ---8.42K | --5.06K | ---11.81K |
End cash Position | -76.84%794.14K | 3,641.22%991.13K | 2,712.91%2.59M | 1,420.50%1.53M | 1,420.50%1.53M | 2,948.47%3.43M | --26.49K | --92.23K | --100.66K | --100.66K |
Free cash from | 14.66%-196.98K | -2,338.82%-1.6M | -13,667.82%-1.16M | -8,087.21%-2.2M | -11,911.43%-1.9M | -1,042.30%-230.84K | ---65.74K | ---8.42K | ---26.91K | --16.07K |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.